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The exact prevalence of epileptic seizures in patients with multiple sclerosis (MS) is still a matter of some 
controversy. In a population-based, unselected group of 423 patients with MS we identified 17 (4.02%) with 
epileptic seizures. The mean age at onset of MS was 25.2 years and at onset of epilepsy 32.6 years. A prevalence of 
‘active epilepsy’, i.e. seizures within the last 5 years, was estimated to 3.2%. The prevalence of epilepsy in our MS 
population is much higher than should be expected when compared to lifetime prevalence of epilepsy in 
corresponding age groups. The occurrence of convulsive status epilepticus is also higher than expected, and 
suggests a rather serious prognosis. Thus, drug treatment should be considered after the first epileptic seizure. 
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INTRODUCTION 
Multiple sclerosis (MS) is a demyelinating dis- 
ease, with symptoms due to impaired central 
impulse propagation. Clinicians often assume a 
low seizure frequency in MS patients. 
Considerable variations in seizure occurrence 
in MS patients are reported, generally in the 
order of OS’-4.5%‘-‘. A recent study showed 
an overall seizure prevalence of 1.7% in MS, 
with 2.3% in cases with definite MS*. Thus, 
the prevalence of seizures in MS is still un- 
certain, and EEG studies have even suggested 
‘epileptic’ abnormalities in up to 10%9. Further- 
more, knowledge is rather sparse concern- 
ing severity and prognosis of epilepsy in MS 
patients. 
Having diagnosed epilepsy in four MS patients 
within 2 years, we examined the occurrence, 
characteristics and prognosis of seizures in our 
MS population. The only Department of Neurol- 
ogy in Hordaland county is in Bergen. Thus, all 
patients with MS and/or epilepsy are likely to be 
referred to our department. 
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METHODS 
We retrospectively evaluated the occurrence of 
epileptic seizures and epilepsy in our population 
of 423 patients (254 female and 169 male) with 
onset and diagnosis of MS between 1958 and 
1988, in the county of Hordaland”. For seizure 
classification, the ILAE terminology of 1981 was 
used (Epilepsia 1981; 22: 489-501). 
RESULTS 
Of 423 MS patients, 17 had epileptic seizures 
(4.02%). Of these, 16 qualified for the diagnosis 
of epilepsy (3.8%) (Table l), and one additional 
patient had an ascertained epileptic seizure and 
repeated EEG registrations showing epileptic or 
epileptiform EEG activity (Table 2). Their mean 
age at onset of MS was 25.2 f 5.6 (sd) years, and 
at onset of epileptic seizures 32.6 f 7.9 years. Of 
these patients, six were males (mean age at 
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Table 1: Classification of multiple sclerosis (MS) in individual patients, with age at onset of MS and epileptic seizure (EpS) and 
delay in seizure occurrence after MS debut 
Patient Sex Type of MS MS EPS Delay 
Onset; age Wars) 
age 
01 FH 
02 FH 
03 AGB 
04 RS 
05 JO 
06 AHH 
07 OK 
08 TV 
09 UT 
10 Ls 
11 IN 
12 TEF 
13 AD 
14 SH 
15 GB 
16 BK 
17 MS 
M 
M 
F 
F 
F 
F 
F 
M 
F 
M 
F 
F 
F 
M 
M 
F 
F 
PRR 
PRR* 
PRR* 
PRR* 
PCP 
PRR 
PRR 
PRR* 
PRR 
PCP 
PRR 
PRR 
PRR 
PRR 
PRR 
PRR 
PCP 
Definite 29 42 
Definite 15 27 
Definite 24 34 
Definite 18 26 
Definite 30 32 
Definite 20 38 
Definite 36 46 
Definite 23 23 
Definite 31 39 
Definite 22 22 
Definite 28 32 
Definite 30 30 
Probable 30 49 
Definite 29 29 
Definite 22 34 
Definite 19 28 
Definite 23 24 
13 
12 
10 
8 
2 
18 
10 
0 
8 
0 
4 
0 
19 
ot 
12 
9 
PRR: Primary ‘Remitting relapsing’. 
PCP: Primary ‘Cronic Progressive’. 
*: PRR, subsequently developing into secondary CP. 
t Patient SH may have had a seizures at the age of 14, 2 years after a slight head trauma. 
seizure onset: 35.6 years) and 11 were females 
(mean age at seizure onset: 42.6 years). On 
January 1st 1992 343 patients were alive. Of 
these, 14 (4.08%) had epilepsy, and 11 had had 
known seizures within the last 5 years (3.2%). 
According to the criteria of MacAlpine”, 16 
patients had definite and one probable MS. 
Fourteen patients had ‘primary remitting relaps- 
ing’ (PRR), and three had ‘primary chronic 
progressive’ (PCP) MS” (Table 1). Of the 
Patient Sex 
Table 2: EEG findings and epileptic seizures in MS patients 
EEG EP. Seizure Seizures 
(Focal 7/6) observation 
AED 
01 FH M R Focal 
02 FH M R Focal 
03 AGB F R Focal 
04 RS F R Focal 
05 JO F L Focal 
06 AHH F L Focal 
07 OK F R Focal 
08 TV M R Focal 
09 UT F R Focal 
10 LS M ? Focal 
11 IN F L Focal 
12 TEF F R Focal 
13 AD F L Focal 
14 SH M R Focal 
15 GB M R Focal 
16 BK F L Focal 
17 MS F R Focal 
+ 
+ 
+ 
- 
+ 
- 
- 
+ 
+ 
- 
+ 
- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
sGTC CBZ 
sGTC CBZ 
sGTC CBZ 
sGTC CBZ 
sGTC PB 
sGTC CBZ 
sGTC CBZ 
sGTC CBZ 
sGTC PHT 
CPS CBZ 
CPS NONE 
sGTC CBZ 
CPS/GTC CBZ 
CPS PHT 
CPS CBZ 
SPS PHT 
sGTC PHT 
All EEGs showed focal 7/6 activity with or without epileptiform or epileptic activity. Seizure observation (+/-), and/or EEG 
allowed diagnosis of a focal epilepsy in all cases. (R: right, L: left). 
?: Uncertain side of focus, in a patient with a limbic, most likely mesial temporal focus. 
sGTC: secondary generalized tonic-clonic, CPS: Complex partial seizures; SPS: Simple partial seizures; Ep: Epileptic, i.e. spikes or 
‘epileptiform,’ i.e. sharp-slow wave activity in EEG; AED: Anti-epileptic drugs: CBZ: Carbamazepines; PB: Phenobarbital; PHT: 
Phenytoin. 
Epileptic seizures in patients with MS 379 
patients with PRR MS, four developed a secon- 
dary chronic progressive (SCP) course (patients 
(Pt) 02-04 and 08; Table 1). 
In all but one of the patients the epilepsy 
started after or concurrent with the onset of MS. 
Patient 14 (SH; Table 1) had an episode of 
‘fainting’, possibly of ‘epileptic origin’ at 14 
years-of-age. He had no epileptic symptoms or 
medication until, at the age of 29, he had MS 
onset and ascertained epileptic seizures. 
MS diagnosis was established, and 10 years after 
the first ascertained epileptic seizure. In this 
patient, investigations, including cerebral angio- 
graphy, did not reveal signs of tumour at the time 
of seizure onset. 
DISCUSSION 
All patients had focal epileptic seizures. The 
diagnosis was based on focal EEG findings 
(n = 7) and/or a good description of the seizure 
development (n = 11) (Table 2). Five patients 
had complex partial seizures (CPS) with or 
without a secondary generalization, suggesting, 
most likely, a lateral or mesial temporal lobe 
focus. One patient had simple partial seizures 
(SPS) of a likely parietal origin, and 11 patients 
had likely cortical or immediate subcortical foci 
with secondary generalized tonic-clonic convul- 
sions (sGTC). 
For some time 16 patients used antiepileptic 
drugs (AED). Of these, 11 used carbamazepine 
(400-800mg daily), four used phenytoin (3- 
400 mg daily) and one used phenobarbital 
(100 mg). At the time of evaluation, 11 patients 
still used AED, and three were without. Three 
patients had died, and had been using AED at 
time of death (Patients 05, 14 and 15). 
The present study supports previous investiga- 
tions suggesting a higher occurrence of epileptic 
seizures in MS patients than in the general 
population 1,2*7.8. Variation in occurrence rates 
between 0.45%13 and 10.8%9 of epilepsy in MS 
hardly reflects intergroup, for instance genetic, 
differences alone. Even if occurrence rates are 
reduced to between 0.5% and 4.5%12 they point 
to methodological differences such as patient 
selection, differences of terminology, i.e. diag- 
nostic criteria of MS, definition of epilepsy and 
lack of differentiation between event-related 
seizures and seizures in epilepsy. Our study is 
based on the total population of MS patients in 
the county of Hordaland from 1958 to 1988l’. The 
diagnosis of both MS and epileptic seizures or 
epilepsy are based on thorough examination of 
the patients at the Department of Neurology, 
Haukeland Hospital. 
Four patients had status epilepticus (SE) 
(23.5%) (Table 3). Patient 02 developed a minor 
sequel. Patient 05 died during the status. Patient 
06 did not develop any ‘detectable’ sequele, and 
patient 14 died 1 year after the SE, mainly due to 
complications of the MS. 
Other causes of epilepsy than MS were 
considered in four cases. Patient 01 had a parietal 
contusion, but a close relative confirmed a seizure 
prior to the trauma. Patient 14 had a slight head 
trauma at 12 years. Patient 16 had episodes of 
hypocalcemia, and in patient 15 a brain tumour 
(astrocytoma) was. diagnosed 22 years after the 
In accordance with Hauser et al.“, we defined 
epilepsy as ‘recurrent, unprovoked seizures,’ 
applying to 16 of our 17 patients. Only one of the 
17 patients had so-called ‘tonic seizures’7,14, 
occuring in addition to other epileptic seizures in 
this patient. In general, all epileptic seizures were 
readily distinguishable from other non-epileptic 
‘paroxysmal’ events “-l’. In all our patients a focal 
epilepsy was diagnosed and the MS considered a 
likely cause of their epilepsy. However, in four 
patients other causes for seizures were con- 
sidered, but were less likely than the MS. 
The female-to-male ratio of 1:8 could suggest a 
preponderance of females among epileptic MS 
patient$. However, this is most likely simply to 
reflect the general MS poulation’. 
Table 3: Patients with convulsive status epilepticus (SE) 
Patient Year Duration 
of SE 
Etiology Treatment Sequele 
02 FH 1989 l-2 days Unknown 
05 IO 1983 >l week Pneumonia? 
06 AHH 1991 lh30min Unknown 
14 SH 1973 lh45min Brain biopsy? 
l Patient died 1974, due to consequence of MS. 
i This patient has had several episodes of convulsive SE, latest in 1996. 
DZP: Diazepam; PHT: Phenytoin. 
DZP + PHT 
DZP/PHT 
DZP 
DZP/PHT 
Minor 
Death 
None?? 
Minor?* 
380 B.A. Engelsen & M. Grenning 
Fig. 1: (a) and (b) show CT scans with focal subcortical 
lesions extending into the gray matter in patient 02 (FH), 
who has an ‘aggressive’ MS. 
Fig. 2: (a) and (b) show MRI scan with subcortical ‘white 
spots’ in the white matter adjacent to, and most likely 
extending into, the gray matter, in patient 06 (AHH), who has 
had repeated episodes of status epilepticus. 
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In accordance with other authors, we could not 
find any clear correlation between epilepic 
seizures and the severity or excacaberbation of 
MS. Intercurrent infections may, in some pati- 
ents, contribute to isolated seizures, but the exact 
prevalence of such a contributing factor is 
uncertain. 
Coincidental association between epilepsy and 
MS may occur’. This is especially the case when 
onset of epilepsy precedes symptoms of MS. In 
three or four (Table 1) of our 17 patients, 
epileptic seizures occurred coincidentally with the 
onset of MS, as judged by clinical symptoms of 
MS. Epilepsy as one feature of the initial attack in 
MS is recognized’.‘,‘*. Most often, however, 
seizures occur following the onset of MS, 
suggesting a causal relation between MS and a 
focal, symptomatic epilepsy].‘*‘. 
Interestingly, a recent study revealed higher 
prevalence of epilepsy in patients with definite 
(2.3%) vs. probable (0.79%) MS8. The mean age 
at onset of epiletpic seizures in our patients was 
32.6 years, which is in accordance with other 
authors’*“, and at an age with low age-specific 
prevalence for epilepsy’2. This fact may further 
support the notion of MS as an etiological factor 
responsible for symptomatic epilepsy in some 
patients. 
The mechanism of epileptogenesis is not clear, 
but demyelinated lesions may act as irritative foci 
and MS plaques are found adjacent to, and 
extending into, the cerebral cortex in general”, 
and in a few autopsied patients with MS and 
epilepsy . ‘B Ectopic impulse generation, edema 
and other inflammatory reactions may contribute 
to abnormal nerve cell activity. 
As, in general, seizures did not correlate with 
signs of activity of MS in our patients, this argues 
against an important role of inflammation in 
seizure initiation. 
Concerning prognosis, Mtiller suggested in 
1949 that in MS ‘the prognosis of epilepsy is 
better than otherwise is the case”‘. Similarly, only 
seven of the 13 patients in Drake & Macrea’s 
study ‘required’ anti-convulsant therapy2. 
Different authors suggest that epilepsy in MS 
patients may fall into two major groups.2,4*‘* In 
one, the seizures are chronic but infrequent and 
unrelated to activity of MS. In the other group, 
seizures are associated with rapidly increasing 
disability and are often difficult to control’. In a 
possible third group, several seizures occur during 
acute relapse, with no recurrent sporadic 
seizures7*‘5*‘6. In the latter group it has been 
suggested that the diagnosis ‘event-related se- 
izures’ might be more adequate than epilepsy”-“. 
Status epilepticus (SE) in four out of 17 
patients suggests a higher risk of SE in MS 
patients than the 2-10% risk suggested for a 
general population of epilepsy patients, depend- 
ing on age and type of epilepsy”. SE in MS seems 
to be ‘rare’ in some populations”, but does 
OCCU?‘*~, i.e. in two of 13 cases2, and may be a 
terminal event in disabled patients18*22. Our 
findings support the notion that SE is a serious 
threat to MS patients with epilepsy, and that 
epilepsy should be considered an important risk 
factor in MS patients. The risk of new seizures, 
SE, and a high prevalence of ‘active epilepsy’ 
suggests a need for early use of AED and close 
follow-up of patients with MS and epileptic 
seizures. 
REFERENCES: 
1. Hopf, H. C. Stamatovic, A. M. and Wahren, W. Die 
cerebralen Anfalle bei der Multiplen Sklerose. Zeirschrifr 
fur Neurologie 1970: 198: 256-279. 
2. Drake, W. E. and Macrae, D. Epilepsy in multiple 
sclerosis. Nellrology 1961; 11: 810-816. 
3. Elian, M. and Dean, G. Multiple sclerosis and seizures. In: 
Epilepsy, The Eight Internarional Symposium (Ed J. K. 
Penry). New York, Raven Press, 1977: pp. 341-344. 
4. Cendrowski, W. and Majkowski, J. Epilepsy in multiple 
sclerosis. Journal of the Neurological Sciences 1972; 17: 
389-398. 
5. Kinnunen, E. and Wikstrom, J. Prevalence and prognosis 
of epilepsy in patients with multiple sclerosis. Epilepsia 
1986; 27: 729-733. 
6. Conomy, J. P. and Schriffer, R. B. Epilepsy in multiple 
sclerosis, an electroence-phalographic and clinical study of 
15 cases. Journal of Neurology 1988 235: Suppl S65. 
7. Matthews, W. B., Acheson, E. D. Batchelor, J. R. and 
Weller R. O., Eds. MacAlpin’s Multiple Sclerosis. 
Edinburgh, Churchill Livingston, 1985. 
8. Gheui, A., Montanini, R. Basso, P. F., Zaffaroni, M., 
Massimo, E. and CazzuUo, C. L. Epilepsy in multiple 
sclerosis. European Neurology 1990; 30: 218-223. 
9. Fuglsang-Fredriksen, V. and Thygesen, P., Seizures and 
psychopathology in multiple sclerosis: an encephalo- 
graphic study. Discussion and pathogenesis. Acta Psy- 
chiarrica et Neurologica Scandinavica 1952; 27: 17-41. 
10. Gronning, M., Riise, T. Kvtie, G., Nyland, H., Larsen, J. 
P., Aarli, J. A. Incidence of multiple sclerosis in 
Hordaland, Western Norway; a fluctuating pattern. 
Neuroepidemiology 1991; 10: 53-61. 
11. MacAlpine, D. The benign form of multiple sclerosis: A 
study based on 241 cases seen within 3 years of onset and 
followed up until the tenth year or more of the disease. 
Brain 1961; 84: 186-203. 
12. Hauser, W. A., Annegers, J. F. and Kurland, L. T. 
Prevalence of epilepsy in Rochester, Minnesota: 1940- 
1980. Epilepsia 1991; 32: 429-445. 
13. Berger, A. Eine Statistik tiber 206 Falle von Multipler 
Sklerose. Jahrb. Psyc. Neural. 1905. 25: 168-188. 
14. Matthew, W. B. Tonic seizures in disseminated sclerosis. 
Brain 1958; 81: 193-206. 
B.A. Engelsen 81 M. Grmning 
15. Matthews, W. B. Paroxysmal symptoms in multiple 
sclerosis. Journal of Neurology. Neurosurgery and Psy- 
chiatry 1975; 38: 617-623. 
16. Osterman, P. 0. and Westerberg, C. E. Paroxysmal 
attacks in multiple sclerosis. Brain 197.5; 98: 189-202. 
17. Twomly, J. A. and Espir, M. L. E. Paroxysmal symptoms 
as the first manifestation of multiple sclerosis. Journal of 
Neurology, Neurosurgery and Psychiatry 1980; 43: 296- 
304. 
18. Trouillas, P. and Coujon, J. Epilepsy with multiple 
sclerosis. Epilepsia 1972; U: 325-333. 
19. Brownell, B. and Hughes, J. T. The distribution of 
plaques in the cerebrum in multiple sclerosis. Journal of 
Neurology, Neurosurgery and Psychiatry 1962; 25: 31% 
320. 
20. Mtiller, R. Studies on disseminated sclerosis with special 
reference to symptomatology, course and prognosis. Acta 
Medica Scandinauica 1949; 133 (Suppl. 222): 1-214. 
21. Shorvon, S. Status Epilepticus. Its Clinical Features and 
Treatment in Children and Adults. Cambridge, University 
Press, 1994. 
22. Allison, R. S. Survival in disseminated sclerosis: a clinical 
study of a series of cases first seen 20 years ago. Brain 
1950; 73: 103-120. 
